UK Government Updates Smoking Cessation Guidelines for Doctors, Recognizes E-Cigarettes as Effective Aid

Apr.12.2022
A new smoking cessation guide for doctors in the UK emphasizes the potential harm reduction and quitting potential of e-cigarettes.

The UK government website has announced that the Office for Health Improvement and Disparities has released an updated quit smoking guide for doctors, highlighting the harm reduction and potential for quitting smoking with the aid of e-cigarettes in the section on smoking cessation aids.

 

It has been reported that currently 52.7% of smokers in the UK want to quit, but relying solely on willpower results in a low success rate. Therefore, professional guidance from doctors is crucial in assisting smokers to effectively use quitting aids and significantly improve their chances of success.

 

It is worth mentioning that this guideline highlights the harm reduction and smoking cessation potential of e-cigarettes in the section on smoking cessation assistance, particularly emphasizing the importance of informing doctors about them. The hope is that doctors can better understand e-cigarettes.

 

There is mounting evidence that shows the significant effectiveness of e-cigarettes as a tool for quitting smoking. A comprehensive review of studies conducted by the Cochrane Collaboration, an international organization of evidence-based medical professionals, in 2021 shows that e-cigarettes have a quit-smoking effect, with a success rate twice that of nicotine replacement therapy and nicotine-free e-cigarettes.

 

Source: Southern News Net.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
ASDF responds to Malaysia's proposed e-cigarette ban: Implementation prospects remain unclear; urges compliant operations and diversified strategies
Regarding the Malaysian government's plan to implement a nationwide ban on the sale and use of e-cigarettes in phases from mid-2026, local e-cigarette brand ASDF told 2Firsts that this move reflects the government's concerns over public health, youth protection and market regulation. However, uncertainties remain regarding the specific implementation methods and pace of enforcement for the policy.
Sep.29
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Ministry of Health (Minzdrav) has expressed support for a full ban on vapes and “nalivayka” alcohol outlets, calling it an effective measure to curb harmful habits and improve public health.
Oct.17 by 2FIRSTS.ai
Company | British American Tobacco launches "Vapers Deserve Better" campaign in the UK, calling for mandatory testing and retail licensing
Company | British American Tobacco launches "Vapers Deserve Better" campaign in the UK, calling for mandatory testing and retail licensing
British American Tobacco UK (BAT UK) announced the launch of its "Vapers Deserve Better" campaign this week, emphasizing the need for a responsible regulatory framework to combat non-compliant operators who ignore regulations and quality standards. The campaign advocates for mandatory pre-market testing, a national retail licensing system, and stricter penalties for offenders.
Sep.29 by 2FIRSTS.ai
Kentucky to Require Tobacco and Vape Retailers to Be Licensed Starting January 2026
Kentucky to Require Tobacco and Vape Retailers to Be Licensed Starting January 2026
The Kentucky Public Protection Cabinet has reminded all businesses selling tobacco, nicotine, and vapor products that they must be licensed by the Kentucky Department of Alcoholic Beverage Control (ABC) by January 1, 2026. The requirement stems from Senate Bill 100, signed into law by Governor Andy Beshear on March 24, 2025, aimed at strengthening youth protection and enforcing compliance against unlicensed sales.
Nov.17 by 2FIRSTS.ai
Ukraine intercepts approximately $40,000 worth of smuggled goods, including a large amount of Elfbar e-cigarettes
Ukraine intercepts approximately $40,000 worth of smuggled goods, including a large amount of Elfbar e-cigarettes
An e-cigarette smuggling operation was uncovered in the Lviv region of Ukraine, resulting in the seizure of 7,500 Elfbar e-cigarettes, valued at over 1.8 million hryvnia (approximately $40,000). The case is under investigation under Ukrainian criminal law.
Sep.23 by 2FIRSTS.ai